INTRODUCTION
Endotoxemia is associated with thrombocytopenia, leukopenia (1) (2) (3) and the appearance of platelet and leukocyte aggregates in the microvasculature, particularly of the lungs (4-6). These hematologic events are thought to underlie the hemodynamic alterations of endotoxemia that is pulmonary hypertension, low cardiac output, and systemic hypotension. The precise mechanisms of injury are unknown, but probably include both mechanical vascular obstruction with release of vasoactive and vasotoxic agents directly from the intravascular aggregates, as well as indirect effects mediated by injured organs such as the liver (7) . The salutary results of the treatment of pulmonary embolism with an infusion of the antiaggregating and smooth muscle relaxing agent prostacyclin (8) prompted a trial of this prostaglandin in the therapy of endotoxemia; an event thought to be characterized by microemboli and disseminated intravascular coagulation.
METHODS
24 adult mongrel dogs weighing [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] kg were anesthetized with sodium pentobarbital 30 mg/kg, paralyzed with pancuronium bromide 0.1 mg/kg (Organon Inc., West Orange, N. J.), and intubated and ventilated with room air using a piston pump (Harvard Apparatus Co., S. Natick, Mass.). Tidal volume was set at 15 ml/kg and the rate at 12 cycles/min. Adjustments in rate were made to yield a PaCO2 of 35-40 mm Hg. Supplemental doses of pentobarbital and pancuronium were added as required to maintain anesthesia and paralysis. A femoral arterial catheter was placed for blood sampling and the measure of mean arterial pressure (MAP)' using a strain gauge transducer (model 800, Bentley Laboratories, Irvine, Calif.). The femoral vein was cannulated for fluid and drug administration. A 7 French, thermister-tipped flow directed pulmonary arterial catheter (Instrumentation Laboratory, Lexington, Mass.) was introduced into the external jugular vein and advanced into the pulmonary artery. This catheter was used to measure central venous (CVP), mean pulmonary arterial (MPAP) and pulmonary arterial wedge pressures (PAWP) using strain gauge transducers (Bentley Laboratories). The catheter was also used for pulmonary arterial blood sampling and cardiac output determinations by thermodilution (Instrumentation Laboratory, model 601). Arterial and mixed venous blood gases, pH, hemoglobin and oxyhemoglobin measurements were made with standard Clark and Severinghaus electrodes and by spectrophotometry (Instrumentation Laboratory, models 282 and 813). Transurethral cannulation of the urinary bladder was performed for meaurement of urinary output. Pulmonary vascular resistance (PVR) was calculated from the ratio MPAP-PAWP/CI and systemic vascular resistance (SVR) from the ratio MAP-CVP/Cl where CI is cardiac index expressed in ml/min kg. Leukocyte and platelet counts were performed using EDTA anticoagulated blood and phase microscopy. Fibrinogen was estimated spectrophotometrically after conversion to fibrin according to the method of Swain and Feders (9) . Fibrin degradation products (FDP) were measured by staphylococcal clumping according to the technique described by Leavelle et al. (10) .
Catecholamine assay. Plasma content of norepinephrine, epinephrine, and dopamine was assayed by a radioenzymatic, thin layer chromatographic procedure (11) . Arterial blood samples were collected in heparin and centrifugated at 5,000 g for 10 min at 4°C. (14) .
Results are expressed as micromoles of tyrosine liberated per milliliter of plasma per hour. Endotoxin, prepared from E. coli (Difco Laboratories, Detroit, Mich.) was dissolved in normal saline (10 mg/ml) jUst before each experiment. Prostacyclin (PGI2) supplied by Dr. Pike, Upjohn Co., Kalamazoo, Mich., was also freshly prepared. It was dissolved in 20 mM Tris buffer (pH 10) and infused uising a specially designed ice-water jacketed syringe system which maintained infusate temperatture <3°C. The rate of drug infusion was 100 ng/kg min using a volume of 3.3 ml/h. Aspirin (Sigmiia Chemical Co.) was dissolved in 8.4%
sodiuim bicarbonate in a concentration of 100 mg/ml (pH 9.0).
All dogs received a rapid intravenous injection of 1.75 mg/ kg endotoxin. Eight animals were then given the Tris buffer without PGI2 and served as untreated controls. 30 min after endotoxin administration, an infusion of PGI2 was started in 10 dogs and was continued over a 3-h period. In six dogs 100 mg/kg aspirin was rapidly injected intravenously 30 min after endotoxin. Hemodynamic measurements, urine output, arterial and mixed venous blood samples were obtained before endotoxin infusion, after 6 min and then at 30-min intervals for 5 h. Hemoglobin levels were kept constant using intravenous infusions of lactated Ringer's solution. Sodium bicarbonate (1 meq/ml) was added to maintain blood pH between 7.35 to 7.40. Heat lamps were used to stabilize body temperature. After 5 h of monitoring, anesthesia was discontinued, pancuronium was reversed with neostigmine 0.06 mg/kg (Roche Diagnostics Div., Nutley, N. J.), and atropine 0.02 mg/kg (Burroughs-Wellcome Co., Research Triangle Park, N. C.). The animals were extubated, observed in their cages for 24 h, and then killed.
Statistical analysis of differences between the three groups was based upon a one-way analysis of variance. Epinephrine values between control and PGI2 groups were analyzed by a repeated measures analysis of variance. A paired t test was used to examine changes within a group. The Chi-square test was employed for mortality studies (15) min after endotoxin to 39±3% (P < 0.001) at 5 h. In control animals VDIVT was 56+3% atthis time (P < 0.005). Platelet and leukocyte count. 6 min after endotoxin, platelet numbers decreased to less than 10% of base line (P < 0.001) and then gradually increased, reaching a plateau of about 100,000 after 60 min in the control group (Fig. 5) . Aspirin did not alter numbers, but with PGI2 platelets slowly rose and after 2.5 h the count of 122,700+10,300 was higher than controls (P < 0.05). The leukocyte count following endotoxin initially declined to <750/mm3 (P < 0.001) and then gradually rose to levels above 4,000/mm3 by 5 h. PGI2 and aspirin were without effect on the leukocyte count.
Fibrinogen and FDP. Fibrinogen levels decreased from 484±52 to 321±28 ,ug/dl in the control group (P < 0.01), from 483±39 to 331±24 mg/dl in the PGI2 group (P < 0.005) and from 464±64 to 227+±47 ,g/dl in the aspirin group (P < 0.001). Fibrinogen remained depressed in the three groups throughout the experiment. 30 min after endotoxin, FDP rose from <0.05 to 36.0±9.6 ,zg/ml and to 52.0±18 ug/ml at 3 h. In the PGI2 treated group, FDP peaked at 54.4±20.0 ,ug/ml and declined significantly (P <0.05, Fig. 6 ). In the aspirin treated group, FDP increased to 53.7±20.0 ,4g/ml after 2 h, similar to the control group. Cathepsin D. Endotoxin injection resulted in a fivefold rise in plasma cathepsin D from 128± 79 to 812± 145 ,uM trypsin/ml -h at 3.5 h in the control group (P <0.001, Fig. 7 ). In the PGI2 group, cathepsin D levels peaked at 602± 162 after 2 h (P < 0.05) and became significantly lower than untreated controls by 3.5 h (P <0.05). Cathepsin D levels in the aspirin group were not significantly different from controls.
Catecholamines. Norepinephrine levels in untreated controls increased threefold 6 fivefold 2 h after endotoxin infusion, and remained elevated during the remaining 3 h period (P < 0.005, Fig. 8 ). Following PCI2, arterial levels of norepinephrine were significantly lower and returned to base-line values by 4 h. In the aspirin group norepinephrine increased fivefold after 2 h and was significantly higher than controls after 4 h (P <0.05). Arterial dopamine initially increased 6 mn following endotoxin (P < 0.005), and remained elevated in all three groups (Table I) . Arterial epinephrine increased more than sevenfold following endotoxin administration (P < 0.01). Neither PGI2 nor aspirin had any significant effect on epinephrine levels.
Survival. In order to maintain a stable hemoglobin and pH, untreated control animals required 705+60 ml/h lactated Ringers solution and 10.0 ml/h bicarbonate; the PGI2 group required 700±+74 ml/h Ringers and 10.2 ml/h bicarbonate; finally, after aspirin 633± 64 ml/h Ringers and 10.0 ml/h bicarbonate were needed. Watery diarrhea was observed in four control, three PGI2 treated and two aspirin treated animals. All eight untreated dogs and six aspirin treated dogs died within 24 h following the administration of endotoxin. 9 out of 10 PGI2 treated animals survived more than 24 h (P < 0.025). (16) , as well as increases in the acid hydrolase cathepsin D (17) . These enzyme elevations are thought to be due to hepatocyte damage with lysosomal disruption caused by leukocyte and erythrocyte aggregates in hepatic sinusoids (18, 19) . Early and prominent hematologic abnormalities are thrombocytopenia and leukopenia. Endotoxin is known to cause platelet clumping (2) . Platelet aggregation and neutrophil stimulation by particulates (20) lead to the generation of prostaglandins. The high levels ofthromboxane (Tx)B2 the stable metabolite of thromboxane A2, within 30 min of the administration of endotoxin (16) while negative inotropic properties of TxB2 may explain in part the reduced flow (17, 21) , although the levels of TxB2 used in in vitro studies were far above anything which can be achieved in vivo. Pretreatment of animals with the cyclo-oxygenase inhibitors indomethacin (22) or ibuprofen (23) and thromboxane synthetase inhibitors, imidazole or 7-( l-imidazolyl)-hepatanoic acid ameliorated the severe thrombocytopenia following endotoxin (24) and prevented the rise of serum acid hydrolase activity of lysosomal origin (23) . Furthermore, many other salutary effects were noted after pretreatment with these cyclo-oxygenase and thromboxane synthetase inhibitors including the maintenance of hepatic function and improved long term survival (16, 17, 22, 23) . These beneficial effects required the prophylactic use of antagonists. In the present study, aspirin given 30 min after endotoxin did not reverse the fall in platelets, nor was there restoration of the rise in FDP and cathepsin D levels. Further, although MAP and MPAP rose, there was no increase in CI; PVR and SVR remained high and there was a fatal outcome. Intravascular coagulation is a prominent event in endotoxemia. Its occurrence was signaled by the fall in platelets and fibrinogen, and the rise in FDP. It is likely that platelet aggregation and disseminated intravascular coagulation were triggered by the same stimulus since imidazole has been reported by Wise et al. (16) to prevent severe thrombocytopenia, as well as limit the rise in FDP. PGI2 is known to inhibit platelet aggregation by causing an increase in cyclic AMP (25) . Our observed rise in platelet counts following PGI2 and fall in FDP indicates the effectiveness of PGI2 in reversing the intravascular coagulopathy.
DISCUSSION
Treatment of endotoxemia with PGI2 significantly modified metabolic events, organ function and survival. We believe the mechanism relates directly to the ability of PGI2 to stimulate cyclic AMP production. Thus, increases in platelet cyclic AMP prevents platelet aggregation, disseminated intravascular coagulation and the generation of negative inotropic agents such as TxB2 (21) The rapid reversal of cardiac dysfunction by PGI2 contrasts with the slow reversal of renal failure and hepatocellular function reflected by urine flow and cathepsin D activity (Figs. 4, 7) . These events may indicate improved cellular function secondary to the PGI2 Reversal of Lethal Endotexremia in Dogs improved perfusion. The delayed restoration of norepinephrine levels with PGI2 may simply be a function of a slow reversal of the state of stress and the stimulus to production (Fig. 8) . The selective reduction of norepinephrine and not dopamine or epinephrine may relate to a direct inhibition of norepinephrine release by PGI2 from sympathetic nerve endings in blood vessels (27) . It is also possible that endotoxin interfered with the pulmonary endothelial clearance of norepinephrine. Normally, 25% of circulating norepinephrine, but not epinephrine or dopamine, is extracted during passage through the lungs (28) . PGI2 may have restored normal pulmonary metabolic function.
Surprisingly, PGI2 did not reverse QST during the 5-h observation period. An infusion of PGI2 into animals made hypoxic with pulmonary emboli led to a lowering of 0'()T within 15-30 min (8) . The failure of PGI2 to promptly reverse respiratory failure in endotoxemia where microemboli are thought to play a prominent role is unexpected (6) and suggests that microemboli, which may possibly have been formed in the lung, were not affected by PGI2 during the limnited 5-h period ofobservation. Studies in septic dogs and patients have shown that platelets and granulocytes are entrapped by the lungs (29, 30) . However, these events correlate poorly with abnormalities in respiratory function. It is likely that other factors are involved in lung damage and the functional abnormalities ofsepsis.
Leukocytes may mediate endothelial damage (31). Neutrophils contain neutral proteases such as collagenase, elastase, and cathepsin D. Following infusion of endotoxin the decrease in leukocyte count may be due to complement-activation and release of complement (C)3a and C5a which are chemotactic and result in sequestration of leukocytes in the microvasculature (29) . During the process of neutrophil activation and degranulation, lysosomal contents may be discharged not only into phagocytic vascuoles within the cell, but may inadvertently escape into plasma (32) . It is conceivable that other toxic oxygen derivatives such as superoxides are also released and cause endothelial cell damage. The natural defenses against these events are the circulating antiproteases and scavengers of superoxide anions.
The potential benefit of PGI2 regarding leukocytes may be outweighed by its inhibitory actions on chemotaxis and the hexose monophosphate shunt (33) . These inhibitory effects may be hazardous during a clinical setting of bacteremia where reticuloendothelial function is important.
The mechanisms whereby PGI2 modifies the response to endotoxemia remain obscure. The results of the current investigation provide evidence of hematologic, biochemical and cardiovascular activities of PGI2 which coincide with improved survival.
